MedWellAI Revenue Surges 647% to $1.08M in H1 FY2026 as Losses Narrow
MedWellAI, Inc., a healthcare AI technology company, reported revenue of $1.08 million for the six months ending December 31, 2025, up from $144,009 in the year-ago period. The company posted a net loss of $939,397, narrowing from a loss of $1.89 million a year earlier.
MedWellAI, Inc., a healthcare AI technology company, reported revenue of $1.08 million for the six months ending December 31, 2025, up from $144,009 in the year-ago period. The company posted a net loss of $939,397, narrowing from a loss of $1.89 million a year earlier. Read more earnings reports.
Revenue for the three months ending December 31, 2025 came in at $548,315, a 284% increase from $142,861 in the same quarter of the prior year. The quarterly net loss was $287,519, less than half the $673,911 loss reported in the year-ago quarter.
The operating loss for the six-month period narrowed to $600,022 from $904,080 a year earlier. For the quarter, the operating loss was $273,988, down from $315,096 in the prior-year quarter.
Balance Sheet Deteriorates
Total assets fell to $460,888 as of December 31, 2025, down from $805,500 six months prior. Cash and restricted cash declined to $137,503 from $401,310 during the same period.
Total liabilities more than doubled to $7.75 million from $3.14 million at the end of June 2025. Current liabilities jumped to $7.68 million from $3.06 million. Stockholders' equity deficit widened to negative $7.45 million from negative $6.62 million.
Cash Flow Pressures Continue
The company burned $255,749 in cash from operations during the six months ending December 31, 2025, compared to $461,576 in the year-ago period. Cash used in investing activities was $8,058, a sharp reversal from the $638,280 generated from investing in the prior-year period.
The company reported no financing activity during either the current or prior-year six-month periods.
Equity Structure
Common shares outstanding increased to 6,236,580 as of December 31, 2025, from 6,186,580 six months earlier. The retained earnings deficit widened to $89.61 million from $88.67 million at the end of June 2025.
| Item | Q2 FY2026 | Q2 FY2025 | H1 FY2026 | H1 FY2025 |
|---|---|---|---|---|
| Revenue | $548,315 | $142,861 | $1,075,806 | $144,009 |
| Operating Loss | ($273,988) | ($315,096) | ($600,022) | ($904,080) |
| Net Loss | ($287,519) | ($673,911) | ($939,397) | ($1,889,958) |
| Cash from Operations | — | — | ($255,749) | ($461,576) |
| Balance Sheet Item | Dec 31, 2025 | Jun 30, 2025 |
|---|---|---|
| Total Assets | $460,888 | $805,500 |
| Cash & Restricted Cash | $137,503 | $401,310 |
| Total Liabilities | $7,752,412 | $3,140,935 |
| Stockholders' Equity | ($7,453,861) | ($6,624,599) |